Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2014; 20(16): 4745-4752
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4745
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4745
Figure 1 Patient disposition during the study.
PPS: Per protocol set; FAS: Full analysis set.
Figure 2 Survival curve for the entecavir and lamivudine groups as determined by the Kaplan-Meier method.
A: 60-d; B: 52-wk.
-
Citation: Zhang Y, Hu XY, Zhong S, Yang F, Zhou TY, Chen G, Wang YY, Luo JX. Entecavir
vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. World J Gastroenterol 2014; 20(16): 4745-4752 - URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4745.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4745